Administration of low-dose cyclosporine alone for the treatment of elderly patients with membranous nephropathy
, “Administration of low-dose cyclosporine alone for the treatment of elderly patients with membranous nephropathy”, vol. 14, pp. 2665-2673, 2015.
This study aimed to investigate the effects of administration of low-dose cyclosporine A (CsA) alone and the combination of low-dose CsA and a low-dose hormone for the treatment of elderly patients with membranous nephropathy. We divided 27 patients into two groups as follows: low-dose CsA group (group A) and the group receiving a combination of a low-dose hormone and low-dose CsA (group B). The treatment and follow-up times were ≥6 months.
